Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
Clinical trial NCT01307891 · COMPLETED
Trial details
- NCT number
- NCT01307891
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2016-06-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.